Industry / Brazil
Eurofarma Trials Cuban Cancer Treatment
June 2008 | Company News AlertBrazil's development bank, BNDES, has invested BRL2.2mn (US$1.3mn) to support Brazilian drugmaker Eurofarma's clinical trials of cancer treatment nimotuzumab. The funding, half of the total cost of the project, forms part of the country's PROFARMA Initiative, which supports the development of Brazil's private pharmaceutical industry. Eurofarma will conduct phase I and phase II clinical trials of the monoclonal antibody (mAb) in combination with chemotherapy and radiotherapy for use in the treatment of cancer of the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
